Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: Development and validation of a classification algorithm.

[1]  E. Neri,et al.  Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice , 2021, Diagnostics.

[2]  G. Russo,et al.  Artificial intelligence applications in medical imaging: A review of the medical physics research in Italy. , 2021, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[3]  R. Paramatti,et al.  MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer. , 2019, European journal of radiology.

[4]  M. Scialpi,et al.  Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy , 2019, Abdominal Radiology.

[5]  R. Beets-Tan,et al.  Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review , 2019, Insights into Imaging.

[6]  European Society of Radiology.  What the radiologist should know about artificial intelligence – an ESR white paper , 2019 .

[7]  E. Medico,et al.  Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Yimin Liu,et al.  Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: A retrospective observational study of 270 patients. , 2018, International journal of surgery.

[9]  Stuart A. Taylor,et al.  Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2017, European Radiology.

[10]  Damiano Caruso,et al.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer , 2017, Oncotarget.

[11]  Gina Brown,et al.  Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales , 2016, World journal of gastroenterology.

[12]  Gina Brown,et al.  Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy , 2016, Diseases of the colon and rectum.

[13]  P. Tekkis,et al.  Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). , 2016, Clinical radiology.

[14]  L. Raffaele,et al.  Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy , 2016, European journal of radiology open.

[15]  E. Neri,et al.  MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy. , 2015, European journal of radiology.

[16]  G. Beets,et al.  Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced? , 2015, International journal of radiation oncology, biology, physics.

[17]  Levente Kovács,et al.  Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy , 2015, PloS one.

[18]  L. Stassen,et al.  Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment , 2015, Annals of Surgical Oncology.

[19]  Y. Huang,et al.  Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study. , 2015, Oncology letters.

[20]  J. Gu,et al.  Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy. , 2015, World journal of gastroenterology.

[21]  Karin Haustermans,et al.  EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. , 2014, European journal of cancer.

[22]  M. Kim,et al.  Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. , 2012, The British journal of radiology.

[23]  G. Beets,et al.  T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer , 2012, European Radiology.

[24]  Gina Brown,et al.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Tae Hyun Kim,et al.  Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. , 2010, International journal of radiation oncology, biology, physics.

[26]  A. Crucitti,et al.  Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  J. Lim,et al.  Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response. , 2010, International journal of radiation oncology, biology, physics.

[28]  G. Beets,et al.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? , 2009, Radiology.

[29]  Muhammad Zubair Shafiq,et al.  Guidelines to Select Machine Learning Scheme for Classification of Biomedical Datasets , 2009, EvoBIO.

[30]  E. Rummeny,et al.  Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. , 2006, Radiology.

[31]  Tae Hyun Kim,et al.  Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[32]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[33]  James R. Dixon,et al.  The International Conference on Harmonization Good Clinical Practice guideline. , 1999, Quality assurance.

[34]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.